TürkiyeResearch and clinical trials
Median eight-year follow-up of five children with VKH disease in Ankara published
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
In Ankara, eye doctors followed five children with VKH disease over a long period. The median follow-up time was eight years. All children were given cortisone and drugs that suppress the immune system. Average vision improved slightly. Still, problems such as cataracts, raised eye pressure, and new blood vessel formation were common in the eyes.
What does it mean for patients and families?
In childhood VKH, vision can often be preserved, but problems frequently arise. That is why regular eye checkups are important. This is a small study of five children.
Source
Scientific paper: Clinical characteristics and long-term outcomes of Vogt-Koyanagi-Harada disease in pediatric age group. BMC Ophthalmology, 2025. DOI: 10.1186/s12886-025-04334-y · PubMed 41013312
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Vogt-Koyanagi-Harada disease (VKH)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.